Albeit more MSI/CMS1 patients who relapse are needed to obtain a more significant prognostic value of HLA-A, it could be concluded that the lack of expression of membrane-associated HLA-A on the tumour is a good prognostic factor in CMS1 stage II CRC patients. This evidence concerns the gene HLA-A and neoplasm.